Literature DB >> 9550415

A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B.

A Münzenmaier1, C Lange, E Glocker, A Covacci, A Moran, S Bereswill, P A Baeuerle, M Kist, H L Pahl.   

Abstract

Helicobacter pylori is an etiologic agent in the development of chronic gastritis, duodenal ulceration, and gastric adenocarcinoma. Exposure of gastric epithelial cells to H. pylori induces secretion of the cytokine IL-8, which plays a pivotal role in the immunopathogenesis of H. pylori infections. Isolated Helicobacter strains differ in their virulence and in their ability to induce cytokine production. High degrees of virulence correlate with enhanced IL-8 production. However, the molecular mechanism of this variance in Helicobacter pathogenicity remains poorly understood. Here we show that H. pylori-mediated IL-8 secretion requires activation of the transcription factor nuclear factor-kappaB (NF-kappaB) in a gastric epithelial cell line. Several H. pylori strains which fail to induce IL-8 secretion do not activate NF-kappaB, while all IL-8-inducing strains activate the transcription factor. Moreover, the antioxidant curcumin, which inhibits NF-kappaB activation, also completely suppresses IL-8 induction by H. pylori. NF-kappaB activation is not mediated by LPSs, since purified H. pylori LPS had no effect on gastric epithelial cells. In contrast, both IL-8 secretion and NF-kappaB activation require a secreted H. pylori product, which is not secreted by strains mutated in picB/cagE, a recently identified putative transport protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9550415

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype.

Authors:  G Le'Negrate; V Ricci; V Hofman; B Mograbi; P Hofman; B Rossi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Rescue of Helicobacter pylori-induced cytotoxicity by red ginseng.

Authors:  Soojin Park; Marie Yeo; Ju-Hyun Jin; Ki-Myung Lee; Jae-Yeon Jung; Ryowon Choue; Sung Won Cho; Ki-Baik Hahm
Journal:  Dig Dis Sci       Date:  2005-07       Impact factor: 3.199

3.  Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation.

Authors:  E Glocker; C Lange; A Covacci; S Bereswill; M Kist; H L Pahl
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  NF-kappaB and ERK-signaling pathways contribute to the gene expression induced by cag PAI-positive-Helicobacter pylori infection.

Authors:  Wataru Shibata; Yoshihiro Hirata; Haruhiko Yoshida; Motoyuki Otsuka; Yujin Hoshida; Keiji Ogura; Shin Maeda; Tomoya Ohmae; Ayako Yanai; Yuzo Mitsuno; Naohiko Seki; Takao Kawabe; Masao Omata
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

5.  Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori.

Authors:  Y Hamanaka; M Nakashima; A Wada; M Ito; H Kurazono; H Hojo; Y Nakahara; S Kohno; T Hirayama; I Sekine
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

6.  cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes.

Authors:  J M Cox; C L Clayton; T Tomita; D M Wallace; P A Robinson; J E Crabtree
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Helicobacter pylori and CagA under conditions of iron deficiency.

Authors:  Jennifer M Noto; Richard M Peek
Journal:  Gut Microbes       Date:  2015

8.  Therapeutic potential of curcumin in gastrointestinal diseases.

Authors:  Sigrid A Rajasekaran
Journal:  World J Gastrointest Pathophysiol       Date:  2011-02-15

9.  A Systematic Review of the Clinical Use of Curcumin for the Management of Gastrointestinal Diseases.

Authors:  Masoumeh Atefi; Mina Darand; Mohammad Hassan Entezari; Tannaz Jamialahmadi; Mohammad Bagherniya; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.